GlassScriptPhysician profile
Alan S Keller
NPI 1669526539
$462.96
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $63.82 · 2021: $179 · 2022: $43.84.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $113.26 | 2019-2021 | |
| Abbvie INC. | $92.48 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $59.78 | 2019-2020 | |
| Allergan, INC. | $58.88 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.08 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $31.94 | 2022 | |
| Bausch Health US, LLC | $13.50 | 2019 | |
| Pfizer INC. | $13.21 | 2019 | |
| Almatica Pharma LLC | $12.71 | 2021 | |
| Avanir Pharmaceuticals, INC. | $12.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.